QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
NASDAQ:MOR

MorphoSys News Headlines

$25.83
-0.05 (-0.19 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.29
Now: $25.83
$26.07
50-Day Range
$25.88
MA: $28.83
$30.66
52-Week Range
$18.21
Now: $25.83
$35.73
Volume96,351 shs
Average Volume36,732 shs
Market Capitalization$3.40 billion
P/E Ratio123.01
Dividend YieldN/A
Beta1.03

Headlines

MorphoSys (NASDAQ MOR) News Headlines Today

Source:
SourceHeadline
Xencor Inc (XNCR) Q4 2020 Earnings Call TranscriptXencor Inc (XNCR) Q4 2020 Earnings Call Transcript
msn.com - February 24 at 1:03 AM
I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid TumorsI-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors
prnewswire.com - February 10 at 8:24 AM
MorphoSys and I-Mab Announce First Patient Dosed in U.S. Phase 1 Study of MOR210/TJ210 in Patients with Advanced CanceMorphoSys and I-Mab Announce First Patient Dosed in U.S. Phase 1 Study of MOR210/TJ210 in Patients with Advanced Cance
bloomberg.com - January 25 at 6:09 PM
MorphoSys AG (MOR) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowMorphoSys AG (MOR) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 20 at 3:51 PM
MorphoSys AG: MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for TafasitamabMorphoSys AG: MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
finanznachrichten.de - January 12 at 7:20 PM
DGAP-News: MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for TafasitamabDGAP-News: MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
marketwatch.com - January 12 at 7:20 PM
MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for TafasitamabMorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
finance.yahoo.com - January 12 at 7:20 PM
MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare ConferenceMorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference
bloomberg.com - January 11 at 3:39 AM
DGAP-News: MorphoSys Appoints Sung Lee as Chief Financial OfficerDGAP-News: MorphoSys Appoints Sung Lee as Chief Financial Officer
marketwatch.com - January 8 at 2:23 AM
MorphoSys Appoints Sung Lee As CFOMorphoSys Appoints Sung Lee As CFO
nasdaq.com - January 6 at 11:23 PM
MorphoSys AG: MorphoSys Appoints Sung Lee as Chief Financial OfficerMorphoSys AG: MorphoSys Appoints Sung Lee as Chief Financial Officer
finanznachrichten.de - January 6 at 6:23 PM
MorphoSys Appoints Sung Lee as Chief Financial OfficerMorphoSys Appoints Sung Lee as Chief Financial Officer
finance.yahoo.com - January 6 at 6:23 PM
DGAP-News: MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application for TafasitamabDGAP-News: MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application for Tafasitamab
marketwatch.com - January 5 at 5:21 PM
MorphoSys : Swiss Regulator Accepts Marketing Authorization Application For TafasitamabMorphoSys : Swiss Regulator Accepts Marketing Authorization Application For Tafasitamab
nasdaq.com - January 5 at 4:58 AM
MorphoSys AG: Corporate Calendar 2021MorphoSys AG: Corporate Calendar 2021
finance.yahoo.com - December 17 at 5:14 PM
MorphoSys AG: Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020MorphoSys AG: Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020
finanznachrichten.de - December 8 at 9:39 PM
MorphoSys AG (MOR) Investor Presentation - SlideshowMorphoSys AG (MOR) Investor Presentation - Slideshow
seekingalpha.com - December 8 at 2:50 PM
DGAP-News: Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020DGAP-News: Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020
marketwatch.com - December 7 at 11:00 PM
DGAP-News: MorphoSys Licensee Announces Approval by the European Commission for Tremfya(R) (guselkumab) for TreatmentDGAP-News: MorphoSys' Licensee Announces Approval by the European Commission for Tremfya(R) (guselkumab) for Treatment
bloomberg.com - December 2 at 6:31 PM
DGAP-News: Thomas Biegi Joins MorphoSys as Head of Corporate CommunicationsDGAP-News: Thomas Biegi Joins MorphoSys as Head of Corporate Communications
marketwatch.com - December 1 at 5:53 PM
Thomas Biegi Joins MorphoSys As Head of Corporate CommunicationsThomas Biegi Joins MorphoSys As Head of Corporate Communications
finance.yahoo.com - December 1 at 4:58 PM
Where Do Hedge Funds Stand On MorphoSys AG (MOR)?Where Do Hedge Funds Stand On MorphoSys AG (MOR)?
finance.yahoo.com - November 29 at 12:25 PM
MorphoSys AG 2020 Q3 - Results - Earnings Call PresentationMorphoSys AG 2020 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 22 at 3:48 PM
MorphoSys AG (MOR) Q3 2020 Earnings Call TranscriptMorphoSys AG (MOR) Q3 2020 Earnings Call Transcript
fool.com - November 12 at 5:10 PM
MorphoSys, Cherry Biolabs in licensing pact for hemibody-based cancer therapyMorphoSys, Cherry Biolabs in licensing pact for hemibody-based cancer therapy
seekingalpha.com - November 12 at 2:43 PM
MorphoSys AG: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with PlamotamabMorphoSys AG: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
finanznachrichten.de - November 11 at 6:33 PM
DGAP-News: MorphoSys and Cherry Biolabs Announce licensing of Hemibody TechnologyDGAP-News: MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
bloomberg.com - November 11 at 6:33 PM
DGAP-News: MorphoSys Reports Nine Months and Third Quarter 2020 ResultsDGAP-News: MorphoSys Reports Nine Months and Third Quarter 2020 Results
bloomberg.com - November 11 at 6:33 PM
Xencor, MorphoSys And Incyte Ink Collaboration DealXencor, MorphoSys And Incyte Ink Collaboration Deal
nasdaq.com - November 11 at 6:33 PM
MorphoSys 9-Month Profit RisesMorphoSys 9-Month Profit Rises
nasdaq.com - November 11 at 6:33 PM
MorphoSys Reports Nine Months and Third Quarter 2020 ResultsMorphoSys Reports Nine Months and Third Quarter 2020 Results
finance.yahoo.com - November 11 at 6:33 PM
DGAP-News: MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and ExpositionDGAP-News: MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and Exposition
marketwatch.com - November 6 at 6:50 PM
Incyte (INCY) Q3 Earnings & Sales Miss, Jakafi Demand StrongIncyte (INCY) Q3 Earnings & Sales Miss, Jakafi Demand Strong
finance.yahoo.com - November 5 at 12:15 PM
MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and ExpositionMorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and Exposition
finance.yahoo.com - November 4 at 6:51 PM
MorphoSys raises FY20 guidanceMorphoSys raises FY20 guidance
seekingalpha.com - October 27 at 5:53 PM
MorphoSys AG Raises its Financial Guidance for the Full Year 2020MorphoSys AG Raises its Financial Guidance for the Full Year 2020
finance.yahoo.com - October 27 at 5:53 PM
MorphoSys Licensee Janssen Receives CHMP Positive Opinion for Tremfya(R) (guselkumab) for Treatment of Adults with AcMorphoSys' Licensee Janssen Receives CHMP Positive Opinion for Tremfya(R) (guselkumab) for Treatment of Adults with Ac
bloomberg.com - October 19 at 4:58 AM
MorphoSys prices €325M convertible bondsMorphoSys prices €325M convertible bonds
seekingalpha.com - October 13 at 3:46 PM
MorphoSys AG Successfully Places EUR 325 Million Convertible BondsMorphoSys AG Successfully Places EUR 325 Million Convertible Bonds
nasdaq.com - October 13 at 3:46 PM
Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible BondsAd hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
uk.finance.yahoo.com - October 13 at 3:40 AM
MORPHOSYS AG Inhaber-Aktien o.N (MOR.SG)MORPHOSYS AG Inhaber-Aktien o.N (MOR.SG)
au.finance.yahoo.com - October 9 at 10:31 PM
Coronavirus latest: Turkey admits to excluding asymptomatic cases from daily tallyCoronavirus latest: Turkey admits to excluding asymptomatic cases from daily tally
ft.com - October 1 at 8:11 AM
MorphoSys CFO steps downMorphoSys' CFO steps down
seekingalpha.com - September 30 at 8:57 PM
Dow Jumps 400 Points Amid Renewed Stimulus HopesDow Jumps 400 Points Amid Renewed Stimulus Hopes
forbes.com - September 30 at 7:17 PM
Dow Jumps 500 Points As Banks And Tech Stocks RallyDow Jumps 500 Points As Banks And Tech Stocks Rally
forbes.com - September 30 at 7:17 PM
A Vaccine Is Coming. So What?A Vaccine Is Coming. So What?
nasdaq.com - September 29 at 11:28 PM
MorphoSys, I-Mab Announces FDA Clearance Of IND Application For MOR210/TJ210 In Patients With Advanced CancerMorphoSys, I-Mab Announces FDA Clearance Of IND Application For MOR210/TJ210 In Patients With Advanced Cancer
benzinga.com - September 27 at 8:08 AM
This could spell a bit of trouble: What Rosenberg, Belski and other analysts think about Mondays market selloff'This could spell a bit of trouble': What Rosenberg, Belski and other analysts think about Monday's market selloff
msn.com - September 22 at 2:24 PM
3 Airline Stocks With Long-Term Potential; Morgan Stanley Says ‘Buy’3 Airline Stocks With Long-Term Potential; Morgan Stanley Says ‘Buy’
nasdaq.com - September 15 at 5:32 PM
Stock Market Prospects As Seen Now By Market-Making FirmsStock Market Prospects As Seen Now By Market-Making Firms
seekingalpha.com - September 11 at 6:48 PM
This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.